D&D Pharmatech Announces Launch of Valted Seq Subsidiary Focusing on Discovery of Neurodegenerative Disease Pathways and Biomarkers to Support…

GYEONGGI-DO, South Korea & GAITHERSBURG, Md.--(BUSINESS WIRE)--D&D Pharmatech, Inc. (D&D), a clinical-stage biotechnology company focused on development and commercialization of revolutionary medicines, today announced the launch of their fourth subsidiary, Valted Seq. D&D Pharmatech is also the parent company of Neuraly, Precision Molecular, and Theraly Fibrosis.

Valted Seq is focused on the discovery of neurodegenerative pathways and biomarkers to inform and accelerate development of new therapeutics and diagnostics, including companion diagnostics which play a critical role in enabling advanced therapeutics. To achieve this, the company has created the worlds largest repository of single-cell sequencing data from high-quality, clinically characterized brain tissues of patients with neurodegenerative diseases including Alzheimers and Parkinsons.

We are excited to be a member of the D&D Pharmatech family of companies and are grateful for their investment which will ultimately improve our ability to diagnose and treat neurodegenerative diseases, said Valina Dawson, Ph.D., Interim Chief Executive Officer of Valted Seq. Valted Seq was founded on the belief that a deeper understanding of neurodegenerative pathways is essential to develop precision therapeutics and identify novel biomarkers to diagnose, guide therapies and monitor some of our most challenging and devastating diseases. We expect this unprecedented repository of single-cell genomics, which Valted Seq will explore using advanced big data analytics, will accelerate progress towards better outcomes for patients. Dr. Dawson is Director of the Neuroregeneration and Stem Cell Programs in the Institute for Cell Engineering at the Johns Hopkins University.

The ongoing collection and comprehensive analysis of thousands of brain tissue samples using Valted Seqs state-of-the-art single-cell analysis technology will support a number of projects including development of a first-in-class liquid biopsy assay for blood-based biomarkers for detection and monitoring of Parkinsons disease. The assay is being developed to be utilized in both internal and external clinical trials for emerging Parkinsons therapies; Valted Seq has already been approached by pharmaceutical companies seeking access to the proprietary biomarker assays. The company continues to expand and has added experienced leaders in bioinformatics and diagnostics to advance the technology through product development and towards commercialization.

We are excited to introduce Valted Seq as one of D&Ds companies, said Dr. Seulki Lee, Chief Executive Officer of D&D Pharmatech. Our subsidiaries, which to date have originated from technologies from leading research institutes, are examples of how D&D and academia have worked in close collaboration to build a powerful engine to accelerate translation of innovation from the academic setting into a framework for commercialization. The launch of Valted Seq exemplifies this successful type of collaboration and represents a model that D&D is extending to other preeminent universities.

In recent years, D&D has invested more than $7 million in sponsored research at leading medical research institutions to advance potentially game-changing healthcare innovations.

By establishing a set of subsidiaries that cover the full spectrum of screening, diagnosis, therapy and therapeutic monitoring of diseases affecting the central nervous system, D&D is creating synergies that would not otherwise be achievable. Three subsidiaries are enabling a comprehensive Total Care approach to neurodegeneration: Valted Seq is identifying novel biomarkers for diagnosing and screening Parkinsons and Alzheimers disease; Precision Molecular is advancing neuromolecular imaging to identify and/or follow patients for therapies being developed by Neuraly and is developing new imaging biomarkers based on Valted Seq discoveries. The academic founders of these subsidiaries remain deeply engaged with each other and industry experts, enabling D&D to create a continuum from groundbreaking science to innovative pipelines.

About D&D Pharmatech

D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The companys product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases. D&D Pharmatech is the parent company of U.S.-based Neuraly Inc., Theraly Fibrosis Inc., Precision Molecular Inc. and Valted Seq, Inc. For more information, please visit http://www.ddpharmatech.com/

Continued here:
D&D Pharmatech Announces Launch of Valted Seq Subsidiary Focusing on Discovery of Neurodegenerative Disease Pathways and Biomarkers to Support...

Biopreservation Market To Reach USD 5.63 Billion By 2027 | Reports and Data – GlobeNewswire

September 08, 2020 19:00 ET | Source: Reports and Data

New York, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The globalBiopreservation Market is forecast to reach USD 5.63 Billion by 2027, according to a new report by Reports and Data. A rise in the incidence of chronic diseases, such as renal, cardiac, cancer, and diabetes, will propel the demand for the market.

According to the International Diabetes Federation (IDF), approximately 463 million adults, in 2019, were living with diabetes, and by the year 2045, the number is expected to rise to 700 million. The disease led to 4.2 million deaths and caused the healthcare sector USD 760 billion. Cancer caused almost 9.6 million deaths in 2018. The number of cases is expected to rise to 30 million by 2040 from 18 million in 2018.

Moreover, factors like varying disease patterns, increasing awareness among the population for general wellness and overall healthcare, flexible government policies and regulations together with the applicability of stem cells in research centers focusing on cancer treatment is estimated to escalate the market demand across regions in the upcoming years.

North America dominates the market owing to the increasing number of manufacturers in the region, the spread of infectious diseases, improved healthcare infrastructure, and the development of various new products. Increasing the production of innovative products and the growth of manufacturers in their countries has led Europe to expand its global presence in the industry supported by mergers and acquisitions that are increasing the global presence of European market players.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3470

The Covid-19 Impact

The market will witness a huge surge as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A significant number of biotech firms are in the middle of the race to investigate the virus's genome and are preparing a viable vaccine. These companies are investigating the virus at an unprecedented rate, and considerable funds are being put into the research. The companies are in trial stage, and the public and private sectors are working continuously for the development of the vaccine. Cash inflow for research in the healthcare sector to find a cure for infectious and autoimmune diseases will aid the market in growth.

Further key findings from the report suggest

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/biopreservation-market

For the purpose of this report, Reports and Data have segmented into the global Biopreservation market on the basis of the type, biospecimen, application, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

Biospecimen Outlook (Revenue, USD Billion; 2017-2027)

Application Outlook (Revenue, USD Billion; 2017-2027)

End Users Outlook (Revenue, USD Billion; 2017-2027)

BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3470

Regional Outlook (Revenue, USD Billion; 2017-2027)

Take a Look at our Related Reports:

Bioprosthetics Market: The increasing prevalence of rheumatoid heart disease, coronary and peripheral artery diseases, and other cardiovascular diseases have led to the increasing demand for long-term treatment and relief, factors that are anticipated to drive bioprosthetics market growth.

Stone Treatment Devices Market: Factors such as mounting geriatric populace, an expansion in the frequencies of stone formation, upsurge in the recurrence of the stone after a medical procedure, a tendency towards minimally invasive procedures are expected to propel the industry in the coming years.

Automated Insulin Delivery Systems Market: Automated Insulin Delivery Systems is an user friendly technology that regulate blood glucose level with the help of continuous glucose monitoring.

Cerebrospinal Fluid (CSF) Management Market: The unique nature of cerebrospinal fluid dynamics in each patient has challenged neurologists, neurosurgeons, and medical device developers. This has led to cumulative demand for advanced cerebral spinal fluid (CSF) management devices.

Sacral Neuromodulation Market: A rise in the prevalence of overactive bladder & urge continence among masses along with the expansion of the geriatric population base across the globe is the key factor driving the market growth.

Central Venous Catheters Market: Catheters are an efficient delivery mechanism for surgical procedures. These are medical devices, which are used for the treatment of a large number of cardiovascular diseases and other chronic disorders.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help clients make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Reports And Data | Web: http://www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkdIn | Twitter | Blogs

Read the original post:
Biopreservation Market To Reach USD 5.63 Billion By 2027 | Reports and Data - GlobeNewswire

Global Cell Isolation Technology Market Insights, Industry Top Manufactures, Analysis and Forecast 2020 to 2025 – The Market Correspondent

MarketsandResearch.biz has newly added a new research report titled Global Cell Isolation Technology Market Growth (Status and Outlook) 2020-2025 which is known to provide comprehensive and detailed information about the market for the projected period from 2020 to 2025. The report inspects the crucial data related to the market. The report focuses on different components of the market including market trends, regional outlook, competitive landscape, key players, business approaches. The report determines the global Cell Isolation Technology market growth and market share for the estimated forecast period. The research report has made through several data exploratory techniques which include primary and secondary research.

The reports objective is to show the development in key regions. The global Cell Isolation Technology market is a database mechanism developed for analysis and access to a large volume of unstructured data. The study analyzes market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, player profiles. The research report investigates the whole growth dynamics of the industry as well as market evaluation, manufacturing approach across distinct topologies and competitive landscape analysis.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/59723

Market Segmentation:

The global Cell Isolation Technology market is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

The study encompasses profiles of major companies operating in the global market. Key players profiled in the report include: Thermo Fisher Scientific, Inc., Merck, Beckman Coulter, Inc., Terumo BCT, BD Biosciences, Bio-Rad Laboratories, Inc., GE Healthcare, Stemcell Technologies,

The report provides in-depth comprehensive analysis for regional segments that covers Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries) in the global Cell Isolation Technology report with market definitions, classifications, manufacturing processes, cost structures, development policies, and plans.

Market segment by type, the product can be split into: Centrifugation, Flow Cytometry, Cell Electrophoresis,

Market segment by regions/countries, this report covers: Stem cell research, Cancer research, Tissue regeneration, In-vitro diagnostics, Other

Moreover in the report, other data models include vendor positioning grid, market timeline analysis, global Cell Isolation Technology market overview, and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. Market players can effortlessly implement strategies with all the data provided to gain a dominant position and beat the competition in the market.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/59723/global-cell-isolation-technology-market-growth-status-and-outlook-2020-2025

Questions Answered By The Global Cell Isolation Technology Market Report With Regards To The Geographical Spectrum of The Market:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact Us Mark Stone Head of Business Development Phone: +1-201-465-4211 Email: [emailprotected] Web: http://www.marketsandresearch.biz

Read more:
Global Cell Isolation Technology Market Insights, Industry Top Manufactures, Analysis and Forecast 2020 to 2025 - The Market Correspondent

Study: Cryopreservation Associated with Loss of Quality in Donor Stem Cell Products – PRNewswire

WASHINGTON, Sept. 4, 2020 /PRNewswire/ -- During the COVID-19 pandemic, many stem cell transplant centers including guidance from the National Marrow Donor Program (NMDP) recommend that stem cell products be frozen for preservation. However, a new study in Blood Advances suggests that the freezing process can decrease the quality of stem cells, particularly if they were manipulated before being preserved, if they had high white blood cell content, or if they were stored for a long period of time.

Stem cells can develop into many different types of cells, so they are often used in treatment to replace or repair damaged organs or tissues. Allogeneic stem cell transplantation, which involves transferring stem cells from a healthy donor to a patient, can treat a variety of diseases, including leukemia, lymphoma, myeloma, thalassemia, and sickle cell disease.

Before the coronavirus outbreak, it was not common to freeze allogeneic donor stem cells prior to infusion. However, due to COVID-19's effects on donor and hospital availability, as well as new travel and transportation restrictions, more transplant centers including the NMDP are recommending cryopreservation.

"Prior to COVID-19, the donor and transplant systems were well coordinated and effective. Now, with irregular flights and closed borders, travel and transportation are not assured," said lead study author Duncan Purtill, MD, of Fiona Stanley Hospital in Western Australia. "Five to seven days before stem cell transplant, the recipient usually starts chemotherapy to remove all their bone marrow cells. Without a healthy transplant to replace the cells on the same day, they would be left with no functioning bone marrow, which would of course be very high risk and carry a poor prognosis. Life literally depends on the safe arrival and immediate infusion of stem cells."

Dr. Purtill and his team analyzed 305 samples of allogeneic stem cell products that were cryopreserved at participating Australian cell processing labs between 2015 and 2019. They found that, on average, the recovery of the stem cell products was 74%. This is considered an acceptable, viable recovery, enabling the cells to be used in transplantation. However, some products did not recover to that level: around 15% of the surveyed products had a cell recovery of less than 50%. In fact, the study found that quality recovery could range as low as just 6%. Such a significant cell loss after thawing may mean that the remaining cells may be too few, or too damaged, to achieve timely bone marrow recovery in the patient after infusion.

"It seems that there is variability in recovery and more work needs to be done to determine why," said Dr. Purtill. "When we freeze stem cells and then thaw them afterwards, we sometimes get unexpected results. In this study we identified some possible factors influencing that variability."

The research team pointed to three possible reasons for the loss of quality in some of the stem cells products they analyzed. First, they noted that prolonged transportation and storage time prior to cryopreservation was associated with a loss of quality. They also found that higher white cell concentration of the product affected its quality. It was thought that the presence of other white cells could adversely affect the stem cells, either by releasing damaging enzymes or chemicals, or else by consuming nutritional elements within the product and resulting in less healthy stem cells. And finally, they pointed out that a small proportion of cells which underwent complex manipulation before being frozen also suffered quality loss for instance, when the cell processing lab removed lymphocytes or washed the product to remove plasma and other noncellular components.

Dr. Purtill and his collaborators expressed hope that their findings could serve to inform and improve stem cell transplantation, collection, and processing procedures. "Our findings could be a note of caution for transplant centers to not take for granted that the frozen product they have received will show perfect recovery once thawed," said Dr. Purtill. "I hope centers will insist on receiving a pilot vial which has been frozen and transported in the same way. They can assess the pilot vial to determine its viability before they use the full product and start chemotherapy for the patient."

Blood Advancesis a peer-reviewed, online only, open access journal of the American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders.

Blood Advances is a registered trademark of the American Society of Hematology.

SOURCE Blood Advances

http://www.bloodadvances.org

Continue reading here:
Study: Cryopreservation Associated with Loss of Quality in Donor Stem Cell Products - PRNewswire

Researchers teamed up to develop a ‘three in one’ HIV treatment and the NIH is throwing in $14.6M – Endpoints News

The NIH is pitching $14.6 million into a three for one HIV research program led by USC and the Fred Hutchinson Cancer Research Center that aims to strike the need for daily medication or even achieve a home run cure.

The five-year grant will back preclinical studies that combine gene editing with technology to improve bone marrow transplants. The potential therapy would engineer a patients own stem cells to fight HIV, and stimulate them to produce new immune cells once reintroduced to the patient.

A home run would be that we completely cure people of HIV, Paula Cannon, a USC professor of molecular microbiology and immunology and co-director of the program, said in a statement. What Id be fine with is the idea that somebody no longer needs to take anti-HIV drugs every day because their immune system is keeping the virus under control, so that it no longer causes health problems and, importantly, they cant transmit it to anybody else.

Hans-Peter Kiem, the Stephanus Family Endowed Chair for Cell and Gene Therapy at Fred Hutch, is the co-director. Harvard University professor David Scadden and Magenta Therapeutics are also collaborating on the project.

The approach was inspired by three patients who appear to have been cured of the virus all of whom received blood stem cell transplants from donors who carried a mutation in the CCR5 gene. One of them, dubbed the Berlin patient, has been off antiretroviral drugs since 2007.

I think of the Berlin patient as proof of principle that replacing the immune system with one thats HIV-resistant by removing CCR5 is a possible way to treat somebody, Cannon said.

The program will study the use of gene editing to remove CCR5 from patients stem cells a process which is already in clinical trial for HIV treatment at City of Hope National Medical Center in Duarte, CA. The stem cells will also be engineered to release antibodies and antibody-like molecules that block HIV.

In addition, the grant will fund a Fred Hutch teams endeavor to adapt CAR-T cell therapy to create stem cells whose progeny target HIV-infected cells.

As for preparing a patient for the transplant,Magenta is working on antibody-drug conjugates to replace mild chemotherapy or radiotherapy typically given before the procedure. And Scadden is researching an injectable gel that could help immune cells repopulate more quickly, avoiding a delay.

HIV infection, which currently affects about 1.2 million Americans, has proved to be exceedingly difficult to cure. In July, Merck and Dewpoint inked a deal that allows the pharma to use the Boston-based biotechs biomolecular condensate technology to develop treatments, and potentially a cure, for the HIV virus. The NIH-funded group is hoping to at least control the virus enough to eliminate the need for daily meds. But at best, theyre also eyeing a long sought-after cure.

This grant funds a team with an overarching goal of developing what our perfect HIV gene therapy would look like, Cannon said. All of these pieces could happen separately, but the fact that the NIH has funded us as a team means that the sum will be so much bigger than the parts.

See the original post here:
Researchers teamed up to develop a 'three in one' HIV treatment and the NIH is throwing in $14.6M - Endpoints News

Stem Cell Market 2020: Share Value Analysis of Top Key Players, Global Size, Consumption Analysis, Trends Forecast to 2024 | Industry Research.co -…

Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Stem Cell market report presents in-depth analysis regarding the development, current trends, industry policies, and regulations implemented in each of the geographical regions. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Stem Cell market report provides an in-depth insight into Stem Cell industry during 2020-2024.

Scope of the Report:

The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.

Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.industryresearch.co/enquiry/pre-order-enquiry/13999718

Key Market Trends:

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.

Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.

Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

Reasons to Buy Stem Cell Market Report:

Purchase this Report (Price 4250 USD for a Single-User License) https://www.industryresearch.co/purchase/13999718

Stem Cell Market Report Covers the Following Questions:

Detailed TOC of Stem Cell Market 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Increased Awareness about Umbilical Stem Cell 4.2.2 Increase in the Approval for Clinical Trials in Stem Cell Research 4.2.3 Growing Demand for Regenerative Treatment Option 4.2.4 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases 4.3 Market Restraints 4.3.1 Expensive Procedures 4.3.2 Regulatory Complications 4.3.3 Ethical and Moral Framework 4.4 Industry Attractiveness- Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Product Type 5.1.1 Adult Stem Cell 5.1.2 Human Embryonic Cell 5.1.3 Pluripotent Stem Cell 5.1.4 Other Product Types 5.2 By Therapeutic Application 5.2.1 Neurological Disorders 5.2.2 Orthopedic Treatments 5.2.3 Oncology Disorders 5.2.4 Diabetes 5.2.5 Injuries and Wounds 5.2.6 Cardiovascular Disorders 5.2.7 Other Therapeutic Applications 5.3 By Treatment Type 5.3.1 Allogeneic Stem Cell Therapy 5.3.2 Auto logic Stem Cell Therapy 5.3.3 Syngeneic Stem Cell Therapy 5.4 By Banking Service and Technology 5.4.1 Stem Cell Acquisition and Testing 5.4.2 Cell Production 5.4.3 Expansion 5.4.4 Sub-culture 5.4.5 Cryopreservation 5.5 By Type of Banking 5.5.1 Public 5.5.2 Private 5.6 Geography 5.6.1 North America 5.6.1.1 US 5.6.1.2 Canada 5.6.1.3 Mexico 5.6.2 Europe 5.6.2.1 UK 5.6.2.2 Germany 5.6.2.3 France 5.6.2.4 Italy 5.6.2.5 Spain 5.6.2.6 Rest of Europe 5.6.3 Asia-Pacific 5.6.3.1 China 5.6.3.2 Japan 5.6.3.3 India 5.6.3.4 Australia 5.6.3.5 South Korea 5.6.3.6 Rest of Asia-Pacific 5.6.4 Middle East & Africa 5.6.4.1 GCC 5.6.4.2 South Africa 5.6.4.3 Rest of Middle East & Africa 5.6.5 South America 5.6.5.1 Brazil 5.6.5.2 Argentina 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Osiris Therapeutics Inc. 6.1.2 Pluristem Therapeutics Inc. 6.1.3 Thermo Fisher Scientific 6.1.4 Qiagen NV 6.1.5 Sigma Aldrich Corporation 6.1.6 Becton, Dickinson and Company 6.1.7 Stem Cell Technologies Inc. 6.1.8 AllCells LLC 6.1.9 Miltenyi Biotec 6.1.10 International Stem Cell Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Omega 3 Products Market Insights on Global Share 2020 Latest Industry Trends, Market Demand, Growth, Opportunities and Forecast 2026

Mattress Supports Market Size and Share Forecast Analysis, Top Key Players, Latest Developments, Growth Factors till 2020 to 2024 | Research Report by Industry Research.co

Automotive Metal Coil Spring Market Growth by Forthcoming Developments 2020 Global Industry Scope, Future Prospects, Manufacturers with Size and Share Analysis till 2026 | Report by Industry Research.co

Healthcare 3D Printing Market Share and Business Development 2020 Future Plans of Top Companies, Growth Size, Industry Share by Latest Trends Forecast to 2025

Human Microbiome Sequencing Market Business Growth Analysis with COVID-19 Impact, Future Trends, Industry Size, Global Share and Demand Status Forecast to 2026 Available at Industry Research.co

Underfloor Heating and Cooling Market Growth, Industry Trends 2020 Size by Regions, Global Industry Share, Sales Revenue and Opportunities till 2026 with COVID-19 Impact

Casing Heads Market Size, Share | Growth Analysis by Revenue, Future Demand Status, Price Analysis by Types and Applications till 2020-2026

Engine Cooling Pumps Market Share and Forecast by 2020 to 2026 | Top Key Players Analysis Covers Regions with Growth Value, Comprehensive Development Strategy, Global Size with Revenue and COVID-19 Impact

Read more:
Stem Cell Market 2020: Share Value Analysis of Top Key Players, Global Size, Consumption Analysis, Trends Forecast to 2024 | Industry Research.co -...

Placental Stem Cell Collection and Storage Market to witness an impressive grow – News by aeresearch

The research report, titled [Global Placental Stem Cell Collection and Storage market 2020 by Manufacturers, Type and Application, Forecast to 2025], presents a detailed analysis of the drivers and restraints impacting the overall market. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of the achievements made by the players in the global Placental Stem Cell Collection and Storage market so far. It also notes the key trends in the market that are likely to be lucrative. The research report aims to provide an unbiased and a comprehensive outlook of the global Placental Stem Cell Collection and Storage market to the readers.

The Placental Stem Cell Collection and Storage market report offers a comprehensive analysis of this industry vertical, emphasizing on the key growth stimulants, opportunities, and constraints projected to shape the market dynamics over the forecast period.

As per industry experts, the market is anticipated to grow significantly, registering a CAGR of XX% over the analysis period of 2020-2025

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/293040

Instabilities in the supply & demand channels due to the stringent lockdown measures imposed to address the COVID-19 pandemic has left numerous companies in disarray. Speaking of the ambiguity of revenues in the near term, businesses are expected to face hindrance even once the economy recovers from the pandemic.

Additionally, the report offers a holistic assessment of various industry segments to infer the revenue projections for the market over the study duration.

Key inclusions of the Placental Stem Cell Collection and Storage market report:

Placental Stem Cell Collection and Storage Market segments covered in the report:

Regional analysis: North America, Europe, Asia-Pacific, South America and Middle East and Africa

Product spectrum: Placental Subtopotent Stem Cells, Placental Hematopoietic Stem Cells, Placental Mesenchymal Stem Cells (MSC) and Placental Maternal Pluripotent Stem Cells

Applications spectrum: Cell Therapy, Beauty Products and Other

Competitive landscape:

Information including major players operating in the market along with the manufacturing facilities as well as competitors of each participant

Questions Answered by the Report:

What will be the size of the global Placental Stem Cell Collection and Storage market in 2025?

What is the current CAGR of the global Placental Stem Cell Collection and Storage market?

Which product is expected to show the highest market growth?

Which application is projected to gain a lions share of the global Placental Stem Cell Collection and Storage market?

Which region is foretold to create the most number of opportunities in the global Placental Stem Cell Collection and Storage market?

Will there be any changes in market competition during the forecast period?

Which are the top players currently operating in the global Placental Stem Cell Collection and Storage market?

How will the market situation change in the coming years?

What are the common business tactics adopted by players?

What is the growth outlook of the global Placental Stem Cell Collection and Storage market?

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/293040

Read more from the original source:
Placental Stem Cell Collection and Storage Market to witness an impressive grow - News by aeresearch

Industrial Centrifuge Market worth $9.0 billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

CHICAGO, Sept. 4, 2020 /PRNewswire/ -- According to the new market research report "Industrial Centrifuge Marketby Type (Sediment, Clarifier, Decanter, Disc, Filter, Basket, Screen), Operation (Batch, Continuous), Design (Horizontal, Vertical), End User (Chemical, Power, Food, Wastewater, Pharmaceutical, Paper) and Region - Global Forecast to 2025", published by MarketsandMarkets,the global Industrial Centrifuge Market is projected to reach USD 9.0 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 4.4% between 2020 and 2025.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59612221

The increasing demand for centrifuges in process industries and the rising need for wastewater management solutions are the major factors driving the growth of this market. However, the high cost of centrifuges is expected to restrain the market growth during the forecast period.

Sedimentation centrifuges to dominated the industrial centrifuge market in 2019

On the basis of type, the market is segmented into sedimentation centrifuges and filtering centrifuges. In 2019, the sedimentation centrifuge segment accounted for the largest share of the market. The wide range of industrial applications, the ability to achieve high speeds, increase in oil and gas explorations, and the rising need for wastewater treatment are the major factors contributing to the growth of this segment.

Browsein-depth TOC on"Industrial Centrifuge Market"

232 Tables 33 Figures 227 Pages

Clarifier segment accounted for the largest share of the sedimentation centrifuge market, by type, in 2019

On the basis of type, the sedimentation centrifuge market is segmented into clarifiers/thickeners, decanter centrifuges, disk stack centrifuges, hydrocyclones, and other sedimentation centrifuges. In 2019, the clarifier/thickener segment accounted for the largest share of the sedimentation centrifuges market. These centrifuges are used in a number of industries, including wastewater treatment, mining, power, beverages, food processing, pharmaceuticals and biotechnology, and chemicals.

North America is the largest regional market for industrial centrifuge in 2019

In 2019, North America accounted for the largest share of the industrial centrifuge market, followed by Europe. The high demand for crude oil, a large number of shale oil and gas drilling activities, government initiatives to manage wastewater, flourishing food processing industry, technological advancements, and government support for the development of innovative centrifugation systems are the key factors driving the growth of the market in North America.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=59612221

Prominent players in the industrial centrifuge market are ANDRITZ AG (Austria), Alfa Laval Corporate AB (Sweden), GEA Group AG (Germany), Mitsubishi Kakoki Kaisha, Ltd. (Japan), Thomas Broadbent & Sons (UK), FLSmidth & Co. A/S (Denmark), Schlumberger Limited (US), Ferrum AG (Switzerland), Flottweg SE (Germany), SIEBTECHNIK TEMA (Germany), HEINKEL Drying & Separation Group (Germany), Gruppo Pieralisi - MAIP S.p.A. (Italy), SPX Flow Inc. (US), HAUS Centrifuge Technologies (Turkey), Elgin Separation Solutions (US), Comi Polaris Systems, Inc. (US), Dedert Corporation (US), US Centrifuge Systems (US), B&P Littleford (US), and Pneumatic Scale Angelus (US).

Browse Adjacent Markets:Medical Devices Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:

https://www.marketsandmarkets.com/RequestBundleReport.asp?id=59612221

Browse Related Reports:

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html

Laboratory Centrifuge Market by Product (Equipment (Multipurpose, Ultracentrifugation), Accessories (Rotor, Tube, Bucket, Plate)), Model (Benchtop, Floor standing), Application (Microbiology, Proteomics) & End User (Hospitals) - Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/laboratory-centrifuge-market-197749088.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish MehraMarketsandMarkets INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [emailprotected] Research Insight: https://www.marketsandmarkets.com/ResearchInsight/industrial-centrifuges-market.asp Visit Our Website: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/industrial-centrifuges.asp

SOURCE MarketsandMarkets

Read more:
Industrial Centrifuge Market worth $9.0 billion by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire

New Comprehensive Report on Cell Separation Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Mitenyi Biotec, BD…

Cell Separation Industry Analysis 2020

TheCell Separation Marketreport enlightens its readers about its products, applications, and specifications. The research enlists key companies operating in the market and also highlights the roadmap adopted by the companies to consolidate their position in the market.By extensive usage of SWOT analysis and Porters five force analysis tools, the strengths, weaknesses, opportunities, and combination of key companies are comprehensively deduced and referenced in the report.Every single leading player in this global market is profiled with their related details such as product types, business overview, sales, manufacturing base, applications, and other specifications.

Major Market Players Covered In This Report:, Mitenyi Biotec, BD Bioscience, STEMCELL Technologies Terumo, pluriSelect, Millipore (Merck), Life Technologies

Click Here To Access The Sample Report:https://grandviewreport.com/sample/20572

Cell SeparationMarket has exhibited continuous growth in the recent past and is projected to grow even more throughout the forecast. The analysis presents an exhaustive assessment of the market and comprises Future trends, Current Growth Factors, attentive opinions, facts, historical information, in addition to statistically supported and trade validated market information.

The Global Cell SeparationMarket Can Be Segmented As

The key product type of Cell Separationmarket are:, Gradient centrifugation, Surface markers separation, Fluorescence activated cell sorting, Magnetic cell sorting

Cell SeparationMarket Outlook by Applications:, Oncology research, Neuroscience research, Stem cell research

To Get This Report At Beneficial Rates:https://grandviewreport.com/discount/20572

The Cell Separationmarket comprising of well-established international vendors is giving heavy competition to new players in the market as they struggle with technological development, reliability and quality problems the analysis report examines the expansion, market size, key segments, trade share, application, and key drivers.

Key players within the Cell Separationmarket are identified through secondary analysis, and their market shares are determined through primary and secondary analysis. The report encloses a basic summary of the trade lifecycle, definitions, classifications, applications, and trade chain structure. Each of these factors can facilitate leading players to perceive the scope of the Market, what unique characteristics it offers and the manner in which it will fulfill a customers need.

By Company Profile, Product Image and Specification, Product Application Analysis, Production Capability, Price Cost, Production Value, Contact Data are included in this research report.

What Cell SeparationMarket report offers: Cell SeparationMarket share assessments for the regional and country-level segments Market share analysis of the highest trade players Cell SeparationMarket Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations) Strategic recommendations on key business segments

The Report Answers Following Questions: Over successive few years, which Cell Separationapplication segment can perform well? Within which market, the businesses ought to establish a presence? Which product segments are exhibiting growth? What are the market restraints which are likely to impede the growth rate? However, market share changes their values by completely different producing brands?

To Know More About The Assumptions in This Market Report:http://grandviewreport.com/industry-growth/Cell-Separation-Market-20572

The report entails detailed profiling of each company, and information on capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments, are also included within the scope of the report. In the end, the Cell SeparationMarket Report delivers a conclusion which includes Breakdown and Data Triangulation, Consumer Needs/Customer Preference Change, Research Findings, Market Size Estimation, Data Source. These factors are expected to augment the overall business growth.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.

Original post:
New Comprehensive Report on Cell Separation Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like Mitenyi Biotec, BD...

Long weekend reads: What are the risks of rushing a vaccine? 1976 offers some troubling warnings. – The Daily Briefing

September 4, 2020 Ben Palmer's reads

Devo co-founder Mark Mothersbaugh had Covid-19and some 'very dark' delusions. Mark Mothersbaugh, co-founder of the band Devo, was hospitalized with Covid-19 in May, and in a recent interview with the Los Angeles Times, Mothersbaugh opened up about his experiencing fighting the disease while on a ventilator in the ICU. Mothersbaugh talks about the "very dark" delusions he experienced while in the hospital, including believing he was in the ICU because someone had hit him in the head with a brick. "I felt blood from being hit," he said. "I was handcuffed to a parking deck downtown. I had this whole elaborate story of how these kids sold me to an ambulance company that then got some sort of payment for delivering Covid patients to their ICUs. I totally believed it."

The century-long history of convalescent plasma. Convalescent plasma has garnered a lot of attention in recent weeksand last month, FDA in a controversial move issued an emergency use authorization for the therapy as potential treatment for Covid-19. Writing for the Smithsonian Magazine, Jillian Mock examines the history of convalescent plasma, which dates back to the late 19th and early 20th century, when it was used to treat measles, Spanish influenza, and a variety of other diseases.

What can happen when you fast-track a vaccine approval? History lends a forbidding answer. Writing in the New York Times, Rick Perlstein explains what happened during the 1976 election year, when former President Gerald Ford accelerated the development and approval of a vaccine against a new strain of the H1N1 viruswhich appeared to be related to the pathogen that caused the 1918 flu pandemic. The vaccine, which the federal government distributed through a mass vaccination campaign, had unexpected side effects. An estimated 450 of the 45 million Americans who were inoculated with the new vaccine developed a rare disorder called Guillain-Barr syndrome, which paralyzes the body, including 30 who died. In the end, the federal government ended its mass vaccination campaignand Ford lost the election.

Scientists discover a key to a longer and healthier lifefor mice. A study published Tuesday in Cell Metabolism showed mice that were given a naturally occurring metabolite were healthier overall, and sicker for shorter periods before dying, when compared with mice in a control group. For the study, scientists at the Buck Institute for Research on Aging evaluated the effects of a metabolite called alpha-ketoglutarate (AKG)which is naturally found in the body and a plays a role in several biological process, including stem cell growthon 18-month-old mice, meaning they were approximately between ages 55 to 66 in human years. The scientists said they hope their research will pave the way for studies on therapies that could improve quality of life among elderly humans.

Continue reading here:
Long weekend reads: What are the risks of rushing a vaccine? 1976 offers some troubling warnings. - The Daily Briefing